But these startling scenarios are under consideration...
Aggregated News
Following a lengthy litigation, the co-founders of the Stem Cell Institute of America and related companies have been prohibited from promoting and selling stem cell therapies under a federal district court order. The court, in the case of Federal Trade Commission and State of Georgia v Steven D Peyroux and others, also issued a separate order requiring the defendants to pay $1,845,0000 in civil penalties and $3,310,146 in refunds to 479 consumers, totalling $5,155,146 million.
This was the result of a complaint lodged in 2021, where the Federal Trade Commission (FTC) and the Attorney General's Consumer Protection Division of Georgia jointly sued the defendants for advertising stem cell treatment to the senior and disabled communities by providing false representations that it would treat various orthopaedic conditions including arthritis. These statements are not backed up by concrete evidence.
The allegation in the complaint was that the stem cell treatment that the defendants provided was comparable or superior to surgery, steroid injections and painkillers. Each procedure was priced at $5,000. Some patients received more than one injection. In addition, the complaint...